DelMar Pharmaceuticals Provides Update on VAL-083 Clinical Trial and Outlines Corporate Objectives for 2015 January 12, 2015 • 8:00 AM EST
DelMar Pharmaceuticals Commences Offer to Exchange Common Stock for Outstanding Warrants January 8, 2015 • 8:00 AM EST